HB2048, titled the Metastatic Breast Cancer Access to Care Act, would amend the Social Security Act to give individuals with metastatic breast cancer the same expedited access to disability insurance benefits and Medicare coverage currently available to people with amyotrophic lateral sclerosis (ALS). Under current law, disability insurance benefits generally involve a waiting period, and Medicare coverage typically begins only after a 24-month waiting period; this bill would eliminate those delays for qualifying individuals with metastatic breast cancer.
The bill applies prospectively to disability insurance applications filed after enactment and to Medicare benefits for months beginning after enactment. In practical terms, it would create a new statutory exception in title II of the Social Security Act for metastatic breast cancer, expanding access to income support and health coverage for a population facing a severe, advanced-stage cancer diagnosis.
Impact
The bill would amend sections 223(a) and 226(h) of the Social Security Act to add metastatic breast cancer to the list of conditions exempt from the usual waiting periods for Social Security disability insurance and Medicare. This would affect the Social Security Administration’s administration of disability claims and the timing of Medicare eligibility for affected beneficiaries, while also increasing federal benefit access for individuals diagnosed with metastatic breast cancer and potentially increasing program costs.
Sentiment
The available context suggests generally favorable sentiment toward the bill. It was introduced with bipartisan support from Representatives Garbarino, Castor, Fitzpatrick, and Chu, which indicates cross-party interest in improving access to care for people with metastatic breast cancer. No committee transcript or vote record was provided, so there is no evidence in the record of organized opposition or a recorded floor debate.
Contention
Because no committee discussion or votes are included, there are no documented points of contention in the provided materials. Any potential debate would likely center on the policy and fiscal implications of creating another categorical exception to Social Security and Medicare waiting periods, but the available record does not show specific objections, amendments, or opposing arguments from members or stakeholders.